Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
Gold M, Amatniek J, Carrillo MC, Cedarbaum JM, Hendrix JA, Miller BB, Robillard JM, Rice JJ, Soares H, Tome MB, Tarnanas I, Vargas G, Bain LJ, Czaja SJ. Gold M, et al. Alzheimers Dement (N Y). 2018 May 24;4:234-242. doi: 10.1016/j.trci.2018.04.003. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955666 Free PMC article. Review.
Building clinically relevant outcomes across the Alzheimer's disease spectrum.
Rentz DM, Wessels AM, Annapragada AV, Berger AK, Edgar CJ, Gold M, Miller DS, Randolph C, Ryan JM, Wunderlich G, Zoschg MC, Trépel D, Knopman DS, Staffaroni AM, Bain LJ, Carrillo MC, Weber CJ. Rentz DM, et al. Among authors: gold m. Alzheimers Dement (N Y). 2021 Jun 26;7(1):e12181. doi: 10.1002/trc2.12181. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 34195350 Free PMC article.
Potential roles of digital technologies in clinical trials.
Czaja S, Gold M, Bain LJ, Hendrix JA, Carrillo MC. Czaja S, et al. Among authors: gold m. Alzheimers Dement. 2017 Sep;13(9):1075-1076. doi: 10.1016/j.jalz.2017.08.001. Alzheimers Dement. 2017. PMID: 28870374 No abstract available.
Improving Alzheimer's disease phase II clinical trials.
Greenberg BD, Carrillo MC, Ryan JM, Gold M, Gallagher K, Grundman M, Berman RM, Ashwood T, Siemers ER. Greenberg BD, et al. Among authors: gold m. Alzheimers Dement. 2013 Jan;9(1):39-49. doi: 10.1016/j.jalz.2012.02.002. Epub 2012 Nov 16. Alzheimers Dement. 2013. PMID: 23164548
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
Boxer AL, Gold M, Feldman H, Boeve BF, Dickinson SL, Fillit H, Ho C, Paul R, Pearlman R, Sutherland M, Verma A, Arneric SP, Alexander BM, Dickerson BC, Dorsey ER, Grossman M, Huey ED, Irizarry MC, Marks WJ, Masellis M, McFarland F, Niehoff D, Onyike CU, Paganoni S, Panzara MA, Rockwood K, Rohrer JD, Rosen H, Schuck RN, Soares HD, Tatton N. Boxer AL, et al. Among authors: gold m. Alzheimers Dement. 2020 Jan;16(1):131-143. doi: 10.1016/j.jalz.2019.06.4956. Epub 2020 Jan 6. Alzheimers Dement. 2020. PMID: 31668596 Free PMC article.
Clinical research in dementia: A perspective on implementing innovation.
Boccardi M, Handels R, Gold M, Grazia A, Lutz MW, Martin M, Nosheny R, Robillard JM, Weidner W, Alexandersson J, Thyrian JR, Winblad B, Barbarino P, Khachaturian AS, Teipel S. Boccardi M, et al. Among authors: gold m. Alzheimers Dement. 2022 Nov;18(11):2352-2367. doi: 10.1002/alz.12622. Epub 2022 Mar 24. Alzheimers Dement. 2022. PMID: 35325508 Free article.
Current directions in tau research: Highlights from Tau 2020.
Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC. Sexton C, et al. Among authors: gold m. Alzheimers Dement. 2022 May;18(5):988-1007. doi: 10.1002/alz.12452. Epub 2021 Sep 28. Alzheimers Dement. 2022. PMID: 34581500 Review.
Revision of the criteria for Alzheimer’s disease: A symposium.
DeKosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC. DeKosky ST, et al. Among authors: gold m. Alzheimers Dement. 2011 Jan;7(1):e1-12. doi: 10.1016/j.jalz.2010.12.007. Alzheimers Dement. 2011. PMID: 21322828
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease.
Maher-Edwards G, Watson C, Ascher J, Barnett C, Boswell D, Davies J, Fernandez M, Kurz A, Zanetti O, Safirstein B, Schronen JP, Zvartau-Hind M, Gold M. Maher-Edwards G, et al. Among authors: gold m. Alzheimers Dement (N Y). 2015 May 7;1(1):23-36. doi: 10.1016/j.trci.2015.04.001. eCollection 2015 Jun. Alzheimers Dement (N Y). 2015. PMID: 29854923 Free PMC article.
3,552 results